FDA Approves Nyxoah Genio 2.1 For Use in DREAM Pivotal Study for Obstructive Sleep Apnea
Genio 2.1’s upgrades are entirely related to the external components of the Genio system, as the implantable stimulator remains unchanged.
Read MoreAuthor: Sree Roy
Large Data Analysis Links Inconsistent Sleep, Hypertension Risk
A study of more than two million nights of sleep and blood pressure data found that irregularities in sleep timing and duration were associated with an increased risk of hypertension.
Read More
Frequent Snorers, Those with Sleep Apnea Less Active During the Day
Researchers examined the relationship between snoring frequency and minutes of sedentary time in three years of data.
Read More
Incannex’s IHL-42X Lowered AHI, ODI in Obstructive Sleep Apnea Phase 2 Trial
The clinical trial assessed three doses of IHL-42X at reducing the AHI in patients with OSA, as well as collected safety data.
Read More
SleepRes Introduces V-Com, a Comfort Accessory to Soften CPAP Peak Inspiratory Flow
At SLEEP 2022, SleepRes LLC introduced the V-Com, a CPAP accessory that the company describes as “training wheels for CPAP.”
Read More